chr11-47442706-C-T

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_005055.5(RAPSN):​c.640G>A​(p.Val214Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000979 in 1,614,262 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00011 ( 1 hom., cov: 33)
Exomes 𝑓: 0.000097 ( 1 hom. )

Consequence

RAPSN
NM_005055.5 missense

Scores

2
6
11

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:3

Conservation

PhyloP100: 7.50

Publications

2 publications found
Variant links:
Genes affected
RAPSN (HGNC:9863): (receptor associated protein of the synapse) This gene encodes a member of a family of proteins that are receptor associated proteins of the synapse. The encoded protein contains a conserved cAMP-dependent protein kinase phosphorylation site, and plays a critical role in clustering and anchoring nicotinic acetylcholine receptors at synaptic sites by linking the receptors to the underlying postsynaptic cytoskeleton, possibly by direct association with actin or spectrin. Mutations in this gene may play a role in postsynaptic congenital myasthenic syndromes. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Apr 2011]
RAPSN Gene-Disease associations (from GenCC):
  • fetal akinesia deformation sequence 2
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • neuromuscular disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: Ambry Genetics
  • congenital myasthenic syndrome 11
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Genomics England PanelApp
  • fetal akinesia deformation sequence 1
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • postsynaptic congenital myasthenic syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.026597321).
BP6
Variant 11-47442706-C-T is Benign according to our data. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122. Variant chr11-47442706-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 476122.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RAPSNNM_005055.5 linkc.640G>A p.Val214Met missense_variant Exon 3 of 8 ENST00000298854.7 NP_005046.2 Q13702-1A0A0S2Z4F8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RAPSNENST00000298854.7 linkc.640G>A p.Val214Met missense_variant Exon 3 of 8 1 NM_005055.5 ENSP00000298854.2 Q13702-1
RAPSNENST00000352508.7 linkc.640G>A p.Val214Met missense_variant Exon 3 of 6 1 ENSP00000298853.3 Q13702-2
RAPSNENST00000529341.1 linkc.640G>A p.Val214Met missense_variant Exon 3 of 5 1 ENSP00000431732.1 E9PK11
RAPSNENST00000524487.5 linkc.532-785G>A intron_variant Intron 2 of 6 5 ENSP00000435551.2 E9PJP9

Frequencies

GnomAD3 genomes
AF:
0.000105
AC:
16
AN:
152258
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000723
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00250
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000267
AC:
67
AN:
251224
AF XY:
0.000214
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000289
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00321
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.0000971
AC:
142
AN:
1461886
Hom.:
1
Cov.:
34
AF XY:
0.0000839
AC XY:
61
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33480
American (AMR)
AF:
0.0000447
AC:
2
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00179
AC:
71
AN:
39700
South Asian (SAS)
AF:
0.0000927
AC:
8
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53416
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
0.0000135
AC:
15
AN:
1112010
Other (OTH)
AF:
0.000745
AC:
45
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
9
18
28
37
46
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000105
AC:
16
AN:
152376
Hom.:
1
Cov.:
33
AF XY:
0.000107
AC XY:
8
AN XY:
74514
show subpopulations
African (AFR)
AF:
0.0000721
AC:
3
AN:
41596
American (AMR)
AF:
0.00
AC:
0
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00250
AC:
13
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68036
Other (OTH)
AF:
0.00
AC:
0
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.439
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000136
Hom.:
0
Bravo
AF:
0.000189
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000280
AC:
34
Asia WGS
AF:
0.00491
AC:
17
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.0000593

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Jun 09, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.640G>A (p.V214M) alteration is located in exon 3 (coding exon 3) of the RAPSN gene. This alteration results from a G to A substitution at nucleotide position 640, causing the valine (V) at amino acid position 214 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Congenital myasthenic syndrome 11 Uncertain:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Fetal akinesia deformation sequence 1 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

RAPSN-related disorder Benign:1
Mar 11, 2024
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Fetal akinesia deformation sequence 1;C4225367:Congenital myasthenic syndrome 11 Benign:1
Oct 03, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.19
BayesDel_addAF
Benign
-0.059
T
BayesDel_noAF
Pathogenic
0.14
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.49
T;.;.
Eigen
Uncertain
0.32
Eigen_PC
Uncertain
0.44
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.97
D;D;D
M_CAP
Benign
0.040
D
MetaRNN
Benign
0.027
T;T;T
MetaSVM
Benign
-0.48
T
MutationAssessor
Benign
1.9
L;L;.
PhyloP100
7.5
PrimateAI
Uncertain
0.73
T
PROVEAN
Benign
-0.89
N;N;N
REVEL
Benign
0.22
Sift
Benign
0.11
T;T;T
Sift4G
Benign
0.15
T;T;T
Polyphen
0.59
P;P;P
Vest4
0.82
MVP
0.72
MPC
0.32
ClinPred
0.058
T
GERP RS
5.1
Varity_R
0.28
gMVP
0.50
Mutation Taster
=59/41
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs201124957; hg19: chr11-47464258; API